Iomed Inc has initiated distribution of a revolutionary new cool compression wrap, Liquid Ice, to its served markets in North America. Liquid Ice was first launched in early 2002. It was named 2002 Sports Product of the Year Runner-Up by Sports Edge magazine.
Manufactured by Americool Inc of Belmont, New Hampshire, Liquid Ice is the world's first self-contained product that serves as a reusable cooling and compression wrap. Needing no refrigeration and cooling for up to two hours, Liquid Ice Wrap offers more benefits and none of the drawbacks of an ice pack. It cools without damaging the skin tissue, provides compression, is both comfortable and flexible, and doesn't limit mobility.
Robert J. Lollini, COO and CFO of Iomed, said, "Liquid Ice is a totally unique cooling method for the physical and occupational therapy and sports medicine markets. Traditionally, clinicians have used conductive cooling methods, such as ice sprays, cold packs and ice to treat patients, all of which have limited effectiveness. Liquid Ice, which uses evaporative cooling, lasts six times longer than conductive cooling methods, doesn't damage skin tissue or limit mobility. We are very proud to add Liquid Ice to our product line and believe this product could change the way cold therapy is applied in our served markets."
Gerhard Hassler, CEO of Americool and inventor of Liquid Ice, said, "We selected Iomed as our North American distributor because of the synergy between our respective product lines. Iomed specializes in bringing novel, high quality products and services to market, and we believe that the quality and breadth of their distribution network gives us a phenomenal advantage in getting Liquid Ice to our target markets. Iomed's iontophoretic drug delivery systems are used by professional, semi-professional and Olympic athletes, which are exactly the markets we are targeting with Liquid Ice. Some of the things that impress me most about Iomed are the commitment toward excellence of its team, their tenure in the market and the quality of the Company's facilities. We are very excited about our relationship with Iomed and look forward to their efforts in getting Liquid Ice into the physical and occupational therapy and sports medicine markets."
The award-winning Liquid Ice product line includes ready-to-use cooling compression wraps in two sizes and a recharger fluid that contains enough concentrate for up to 40 applications.
Iomed is a leader in the development, manufacture and sale of active drug transport systems primarily used to treat acute local inflammation in the sports and occupational medicine and physical therapy markets. The Company is seeking opportunities to market or develop new products designed to improve the quality and efficiency of medical care in its served markets. In addition, the Company is seeking collaborative opportunities to develop its non-invasive drug delivery technology to satisfy substantial unmet medical needs. Iomed has proprietary technology in various stages of research and product development for the treatment of acute local inflammation and for the treatment of ophthalmic disease.